Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.45
-0.40 (-2.52%)
At close: Aug 10, 2026, 4:00 PM EDT
15.30
-0.15 (-0.97%)
After-hours: Aug 10, 2026, 5:42 PM EDT
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of $2.06 billion as of August 10, 2026. Its market cap has increased by 37.35% in one year.
Market Cap
2.06B
Enterprise Value
1.68B
1-Year Change
37.35%
Ranking
Category
Stock Price
$15.45
ChartMarket Cap Chart
Since September 3, 2014, Aurinia Pharmaceuticals's market cap has increased from $125.50M to $2.06B, an increase of 1,537.96%. That is a compound annual growth rate of 26.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 2.06B | -2.25% |
| Dec 31, 2025 | 2.10B | 63.56% |
| Dec 31, 2024 | 1.29B | -0.41% |
| Dec 29, 2023 | 1.29B | 110.29% |
| Dec 30, 2022 | 613.90M | -79.30% |
| Dec 31, 2021 | 2.97B | 69.58% |
| Dec 31, 2020 | 1.75B | -8.45% |
| Dec 31, 2019 | 1.91B | 233.25% |
| Dec 31, 2018 | 573.20M | 50.68% |
| Dec 29, 2017 | 380.40M | 366.75% |
| Dec 30, 2016 | 81.50M | 3.69% |
| Dec 31, 2015 | 78.60M | -31.17% |
| Dec 31, 2014 | 114.20M | -9.00% |
| Sep 3, 2014 | 125.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 2.24B |
| ADMA Biologics | 2.23B |
| Biohaven | 2.21B |
| Rapport Therapeutics | 2.18B |
| AbCellera Biologics | 2.12B |
| Stoke Therapeutics | 2.11B |
| Taysha Gene Therapies | 2.10B |
| GH Research | 2.08B |